Italy: Stevanato ups and prices underwritten public offering
New York-listed Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has...
Italy: Stevanato launches US$300m underwritten public offering
New York-listed Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has...
Switzerland: Galderma pries IPO at top of the range to raise CHF2.0bn
Galderma Group, the pure-play dermatology company, has priced its IPO at CHF53 per share, the top of the announced price range to raise CHF2.0bn,...
UK: Kester Capital closes Kester Capital III at £200m hard cap
Kester Capital, a UK lower mid-market private equity firm, has announced the final close of its latest fund, Kester Capital III. The fund was...
UK: Johnson Matthey sells Medical Devices Business to Montagu for US$700m
Montagu Private Equity, a European mid-market private equity firm, is acquiring Johnson Matthey’s Medical Device Components business (MDC) for US$700m on a cash free...
Switzerland: Sonic strengthens Swiss operations with Dr Risch
Sonic Healthcare, the ASX-listed global provider of medical diagnostics,, has added to its Swiss laboratory network with the acquisition of the Dr Risch laboratory...
US: Forbion co-leads oversubscribed US$157m Series B in Engrail Therapeutics
European life sciences VC firm, Forbion, has co-led a US$157m Series B financing round in Engrail Therapeutics, a US based precision neuroscience company. Forbion...
UK: Pfizer raises US$3.5bn from Haleon secondary share sale and buyback
American pharma, Pfizer, has sold a 9.4% stake in Haleon, the UK-based global consumer health company, in a public offering and buyback transaction that...
Canada: AstraZeneca targets radioconjugates with acquisition of Fusion Pharmaceutical
Global pharmaceutical company, AstraZeneca, is acquiring Fusion Pharmaceuticals, a Canada-based clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs) for up to US$2.4bn.
AstraZeneca will acquire all...
Germany: Mahana Therapeutics accelerates into Europe with Cara Care
Mahana Therapeutics, a US-based provider of digital chronic condition management programmes, has acquired Berlin-based digital health company, HiDoc Technologies, which offers the Cara Care...
Advertisement
